• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
NewslettersBrainstorm Health

The Source of Facebook’s Anti-Vaccine Ads

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
November 15, 2019, 5:30 PM ET

This is the web version of Brainstorm Health Daily, Fortune’s daily newsletter on the top health care news. To get it delivered daily to your in-box, sign up here.

Happy Friday, readers!

A new report finds that just two groups are responsible for the majority of anti-vaccine misinformation spread on Facebook.

The study, published in the journal Vaccine, used Facebook’s Ad Archive feature to hunt down the offenders. It was a relatively simple query—search the keyword “vaccine” in the archive between December 2018 and February 2019, and then assess whether the content was promoting, discouraging, or generally discussing vaccine use.

As it turns out, about 54% of the anti-vaccine ad content was funded by the World Mercury Project—a group chaired by noted anti-vaxxer Robert F. Kennedy Jr.—and an organization literally dubbed Stop Mandatory Vaccinations.

The researchers from the University of Maryland, Johns Hopkins, and George Washington University admonished Facebook’s role in spreading the content.

“A small set of anti-vaccine advertisement buyers have leveraged Facebook advertisements to reach targeted audiences,” the wrote. “By deeming all vaccine-related content an issue of ‘national importance,’ Facebook has further politicized vaccines.”

Facebook has been juggling this kind of backlash with a number of initiatives including a tweak that points users to public health organizations like the WHO or CDC when they search for information on vaccines. But the platform’s ad structure, it seems, could continue to be a problem.

Read on for the day’s news, and have a wonderful weekend.

Sy Mukherjee
sayak.mukherjee@fortune.com
@the_sy_guy

DIGITAL HEALTH

Apple says goodbye to vaping apps on its app store. The end of an era—Apple is nixing vaping apps on from its eponymous app store for, well, pretty evident reasons. The CDC reported in its latest update on vaping-related illnesses that thousands of people have been sickened by (and at least 40 have died) from lung injuries seemingly associated with vaping. While it seems like the vast majority of these cases are associated with illicit THC products (and specifically a compound called vitamin E acetate), it's understandable that Apple wants to get out of the game for now. The company has never actually sold such products, but certain apps would have allowed users to control functions such as temperature and lighting on their vaping devices (and otherwise allowed access to vaping networks). (Axios)

INDICATIONS

Novartis wins approval for sickle cell drug. The Food and Drug Administration (FDA) on Friday approved Novartis' experimental treatment for the sickle cell drug Adakveo. It's the first such medicine approved for a painful complication of the rare blood disorder called "vaso-occlusive crisis," which can cause intense bouts of pain. Novartis stock was up modestly in Friday trading. (Reuters)

REQUIRED READING

Americans to Companies: We Don't Trust You With Our Personal Data, by Danielle Abril

Giphy's Toxic Content Problem, by David Z. Morris

Is Silicon Valley Still the World's Greatest Wealth-Generation Machine?, by Polina Marinova

Sign up for other Fortune newsletters.

IF YOU LIKE THIS EMAIL...

Share today’s Brainstorm Health with a friend.

Did someone share this with you?Sign up here. For previous editions, click here.

For even more, check out raceAhead, Fortune's daily newsletter on culture in corporate America. Sign up here.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Newsletters

NewslettersMPW Daily
Alexis Ohanian believes in the future of women’s sports: ‘I can market excellence all day long’
By Emma HinchliffeDecember 12, 2025
9 hours ago
NewslettersCFO Daily
SEC chair moves to boost IPO momentum: ‘Make it cool to be a public company’
By Sheryl EstradaDecember 12, 2025
12 hours ago
NewslettersTerm Sheet
Disney plus OpenAI: What could possibly go wrong?
By Alexei OreskovicDecember 12, 2025
14 hours ago
Disney CEO Bob Iger in Los Angeles, California on November 20, 2025.(Photo: Unique Nicole/AFP/Getty Images)
NewslettersFortune Tech
Disney and OpenAI do a deal
By Andrew NuscaDecember 12, 2025
15 hours ago
NewslettersCEO Daily
Honest Company CEO Carla Vernón on being mentored by Walmart’s Doug McMillon
By Diane BradyDecember 12, 2025
16 hours ago
Stephanie Zhan, Partner Sequoia Capital speaking on stage at Fortune Brainstorm AI San Francisco 2025.
AIEye on AI
Highlights from Fortune Brainstorm AI San Francisco
By Jeremy KahnDecember 11, 2025
1 day ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
15 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
placeholder alt text
Success
Palantir cofounder calls elite college undergrads a ‘loser generation’ as data reveals rise in students seeking support for disabilities, like ADHD
By Preston ForeDecember 11, 2025
1 day ago
placeholder alt text
Arts & Entertainment
'We're not just going to want to be fed AI slop for 16 hours a day': Analyst sees Disney/OpenAI deal as a dividing line in entertainment history
By Nick LichtenbergDecember 11, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
10 hours ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
16 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.